The inaugural AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants is a new grant mechanism that seeks to stimulate creative approaches to translate basic research into new treatment options for kidney cancer.
Applications are invited from researchers currently in the field as well as investigators with experience in other areas of cancer or biomedical research who have promising ideas and approaches that can be applied to kidney cancer research.
The grants provide $50,000 over one year for expenses related to the research project, which may include salary and benefits of the grant recipient and any collaborators, postdoctoral or clinical research fellows, graduate students (including tuition costs associated with graduate students’ education and training), or research assistants; research/laboratory supplies; equipment; publication charges for manuscripts that pertain directly to the funded project; and other research expenses. Indirect costs are not allowed.
Deadline: April 11, 2024
Applicants must have a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree.
At the start of the grant term on August 1, 2024, applicants must:
- Be independent investigators and be affiliated with an academic, medical, or non-profit research institution.
- If eligibility is based on a future position, the position must be confirmed at the time of application, and CANNOT be contingent upon receiving this grant.
- If the future position is at a different institution than the applicant’s current institution, the applicant must contact AACR’s Research and Grants Administration Department (the AACR’s RGA) at grants@aacr.org before submitting their application for information on additional verification materials/signatures that may be required.
- Work at an academic, medical, or research institution anywhere in the world.